At a Glance
Dosage
Only in 25B-NBOMe
insufflated
| Level | Dose |
|---|---|
| Threshold | 25 µg |
| Light | 50–200 µg |
| Common | 200–350 µg |
| Strong | 350–500 µg |
sublingual
| Level | Dose |
|---|---|
| Threshold | 50 µg |
| Light | 100–300 µg |
| Common | 300–500 µg |
| Strong | 500–700 µg |
Only in 1cP-LSD
oral
Duration
Only in 25B-NBOMe
sublingual
Total: 8 hrs – 12 hrsPeak
Offset
Afterglow
Onset20 min – 40 min
Come Up30 min – 1.5 hrs
Peak4 hrs – 6 hrs
Offset2 hrs – 4 hrs
Effects
Safety
Interaction: 25B-NBOMe + 1cP-LSD
No direct interaction data available between these substances. This does not mean the combination is safe.
25B-NBOMe — Dangerous Interactions
No dangerous interactions recorded.
1cP-LSD — Dangerous Interactions
No dangerous interactions recorded.
Frequently Asked Questions
What is the difference between 25B-NBOMe and 1cP-LSD?
25B-NBOMe is classified as a Psychedelic (Substituted phenethylamines) while 1cP-LSD is classified as a Psychedelic (Lysergamides). They share 36 effects in common, with 6 effects unique to 25B-NBOMe and 41 unique to 1cP-LSD.
Is it safe to combine 25B-NBOMe and 1cP-LSD?
There is no direct interaction data available for combining 25B-NBOMe and 1cP-LSD. This does not mean the combination is safe. Always exercise caution and research thoroughly.
Which is stronger, 25B-NBOMe or 1cP-LSD?
25B-NBOMe and 1cP-LSD are typically administered via different routes, making a direct potency comparison difficult. They belong to different pharmacological profiles and should not be compared by dose alone.